Development of homomultimers and heteromultimers of lung cancer-specific peptoids. - Wikidata - wikimedia - TriplyDB

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

http://www.wikidata.org/entity/Q34105317

about

Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.Cell Penetrating Peptoids (CPPos): Synthesis of a Small Combinatorial Library by Using IRORI MiniKans.Unbiased Selection of Peptide-Peptoid Hybrids Specific for Lung Cancer Compared to Normal Lung Epithelial Cells.Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.Antifouling glycocalyx-mimetic peptoids.A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1.

P2860

Q35051889-E9C8791E-ED88-4FA4-ABA6-F9F9F8AFF24E Q35054667-908F7B86-75B2-470D-B871-7CCC6117123F Q35824207-EE6C5FA7-F857-4D97-BB89-DF2E5BA1F4D8 Q38754135-3A2A5A47-67B1-4A35-8A5C-083DDA94E35A Q42117834-712213D6-26B3-4EC2-B96C-3B85577F0957 Q48791049-D0E84FF9-BF7A-4E5B-91E7-EDB4DC78ACA4

P2860

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

http://www.wikidata.org/entity/Q34105317

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@ast

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@en

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@nl

type

label

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@ast

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@en

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@nl

prefLabel

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@ast

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@en

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@nl

P1433

Q34105317-1D5E0C66-70B8-4B30-90D4-2C65F721D7BD

P1476

Q34105317-0A5B3086-0F93-4373-83C2-F22D3256A2A4

P2093

Q34105317-175B0A82-17B4-467E-B113-A66279076A91

Q34105317-37404C59-A04F-4FB8-BDCE-395A51A1DB22

Q34105317-437A5899-F73D-47F6-B707-7E21908C569E

P2860

Q34105317-013D2C19-0708-45E3-8681-52BEAC786334

Q34105317-022CD24C-1F0A-48C6-B424-BC9D79C6113C

Q34105317-05741D8F-BED0-4FDE-9E12-F432CC21231F

Q34105317-0D1C1B19-E8B6-4AE0-9AE5-02E0C371F77D

Q34105317-1015BBB0-B349-4657-9699-BEEB58C10FFF

Q34105317-27B58FA7-1149-4E8E-B8C1-8A224D7B64A4

Q34105317-280E96F6-CC7E-4E47-B0ED-3EF39F1E539E

Q34105317-284AA7F4-0A37-4697-9BB8-779C67FACB62

Q34105317-2D1B7AEC-60D6-4E28-8228-234EA7C2823F

Q34105317-2DFDCE09-8731-4B6F-8789-6FF6F5A95CDA

P304

Q34105317-9B202659-C3AA-46E8-A353-1B72F35DD133

P31

Q34105317-FBA6DCE9-E201-4B32-9B8B-B034BF48BF84

P356

Q34105317-15DD5C2E-E7FE-4485-A2D4-6F72D1D3F6FE

P433

Q34105317-C2048962-2415-497D-AE16-91FB2F78E110

P478

Q34105317-A14E3CBC-FF25-4317-ACF8-3C6006F69878

P577

Q34105317-25C3BFD2-43D6-4981-ACC7-3A0F159C0718

P698

Q34105317-473C221E-DBC6-41D4-A621-A6B121152EC6

P932

Q34105317-280E2082-4794-48F5-9040-E7AE06EE93E8

P356

P1433

P1476

Development of homomultimers and heteromultimers of lung cancer-specific peptoids.

@en

P2093

D Gomika Udugamasooriya

http://www.w3.org/2001/XMLSchema#string

Jared C Hooks

http://www.w3.org/2001/XMLSchema#string

Jaya P Matharage

http://www.w3.org/2001/XMLSchema#string

P2860

Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites

Design of new anti-tumor agents interrupting deregulated signaling pathways induced by tyrosine kinase proteins. Inhibition of protein-protein interaction involving Grb2

Design and synthesis of cyclic RGD pentapeptoids by consecutive Ugi reactions.

Supramolecular compounds from multiple ugi multicomponent macrocyclizations: peptoid-based cryptands, cages, and cryptophanes.

Designing a polyvalent inhibitor of anthrax toxin.

Metallopeptoids.

Cyclic poly(alpha-peptoid)s and their block copolymers from N-heterocyclic carbene-mediated ring-opening polymerizations of N-substituted N-carboxylanhydrides.

Isolation of protein ligands from large peptoid libraries.

Cell-specific delivery of a chemotherapeutic to lung cancer cells.

Therapeutic cancer targeting peptides.

P304

567-577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIP.21596

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22180904

http://www.w3.org/2001/XMLSchema#string

P932

4515028

http://www.w3.org/2001/XMLSchema#string